Page last updated: 2024-09-03

sulbactam and Kawasaki Disease

sulbactam has been researched along with Kawasaki Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Akat, H; Laloglu, F; Orbak, Z1
Han, SB; Lee, SY1

Other Studies

2 other study(ies) available for sulbactam and Kawasaki Disease

ArticleYear
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
    Cardiology in the young, 2021, Volume: 31, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Drug Combinations; Enoxaparin; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lung; Male; Mucocutaneous Lymph Node Syndrome; Oseltamivir; Oxygen Inhalation Therapy; Ritonavir; Sulbactam; Tomography, X-Ray Computed

2021
Antibiotic use in children with Kawasaki disease.
    World journal of pediatrics : WJP, 2018, Volume: 14, Issue:6

    Topics: Age Factors; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; C-Reactive Protein; Cefotaxime; Child, Preschool; Diagnosis, Differential; Diagnostic Errors; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Leukocytosis; Male; Mucocutaneous Lymph Node Syndrome; Pyuria; Republic of Korea; Retrospective Studies; Sulbactam

2018